Zobrazeno 1 - 10
of 1 135
pro vyhledávání: '"Ikenaga Y"'
Autor:
Shogenji M; Faculty of Health Sciences, Institute of Medical, Pharmaceutical and Health Sciences, Kanazawa University, Ishikawa, Japan., Yoshida M; Department of Women's Health Nursing & Midwifery, Tohoku University Graduate School of Medicine, Miyagi, Japan., Sumiya K; Department of Clinical Pharmacokinetics, Graduate School of Medical Sciences, Kanazawa University, Ishikawa, Japan., Shimada T; Department of Clinical Pharmacokinetics, Graduate School of Medical Sciences, Kanazawa University, Ishikawa, Japan.; Department of Hospital Pharmacy, University Hospital, Kanazawa University, Ishikawa, Japan., Ikenaga Y; Department of Rehabilitation Medicine, Yawata Medical Center, Ishikawa, Japan., Ogawa Y; Department of pharmacy, Komatsu Municipal Hospital, Ishikawa, Japan., Hirako K; Frontier Science and Social Co-creation Initiative, Kanazawa University, Ishikawa, Japan., Sai Y; Department of Clinical Pharmacokinetics, Graduate School of Medical Sciences, Kanazawa University, Ishikawa, Japan.; Department of Hospital Pharmacy, University Hospital, Kanazawa University, Ishikawa, Japan.
Publikováno v:
Neurourology and urodynamics [Neurourol Urodyn] 2022 Jun; Vol. 41 (5), pp. 1109-1120. Date of Electronic Publication: 2022 Mar 30.
Autor:
Sumiya K; Department of Clinical Pharmacokinetics, Graduate School of Medical Sciences, Kanazawa University, Kanazawa, Ishikawa, Japan., Shogenji M; Faculty of Health Sciences, Institute of Medical, Pharmaceutical and Health Sciences, Kanazawa University, Ishikawa, Japan., Ikenaga Y; Department of Rehabilitation Medicine, Yawata Medical Center, Ishikawa, Japan; Council of Kaga Local Stroke Network, South Ishikawa, Japan., Ogawa Y; Council of Kaga Local Stroke Network, South Ishikawa, Japan; Department of Pharmacy, Komatsu Municipal Hospital, Ishikawa, Japan., Hirako K; Frontier Science and Social Co-creation Initiative, Kanazawa University, Ishikawa, Japan; The Establishment Preparation Office for The Faculty of Interdisciplinary Economics, Kinjo University, Ishikawa, Japan., Fujita A; Department of Clinical Pharmacokinetics, Graduate School of Medical Sciences, Kanazawa University, Kanazawa, Ishikawa, Japan; Department of Hospital Pharmacy, University Hospital, Kanazawa University, Ishikawa, Japan., Shimada T; Department of Clinical Pharmacokinetics, Graduate School of Medical Sciences, Kanazawa University, Kanazawa, Ishikawa, Japan; Department of Hospital Pharmacy, University Hospital, Kanazawa University, Ishikawa, Japan. Electronic address: t-shimada@staff.kanazawa-u.ac.jp., Hashimoto M; Temari Pharmacy, Ishikawa, Japan., Masuda A; Komeya Pharmacy, Ishikawa, Japan., Nagamoto T; Komeya Pharmacy, Ishikawa, Japan., Tamai I; Division of Pharmacy, Graduate School of Pharmaceutical Sciences, Kanazawa University, Ishikawa, Japan; AI Hospital/Macro Signal Dynamics Research and Development Center, Kanazawa University, Ishikawa, Japan., Ogura H; AI Hospital/Macro Signal Dynamics Research and Development Center, Kanazawa University, Ishikawa, Japan; Department of Nephrology and Laboratory Medicine, Institute of Medical, Pharmaceutical and Health Sciences, Kanazawa University, Ishikawa, Japan., Toyama T; AI Hospital/Macro Signal Dynamics Research and Development Center, Kanazawa University, Ishikawa, Japan; Department of Nephrology and Laboratory Medicine, Institute of Medical, Pharmaceutical and Health Sciences, Kanazawa University, Ishikawa, Japan., Wada T; Department of Nephrology and Laboratory Medicine, Institute of Medical, Pharmaceutical and Health Sciences, Kanazawa University, Ishikawa, Japan., Sai Y; Department of Clinical Pharmacokinetics, Graduate School of Medical Sciences, Kanazawa University, Kanazawa, Ishikawa, Japan; Department of Hospital Pharmacy, University Hospital, Kanazawa University, Ishikawa, Japan; AI Hospital/Macro Signal Dynamics Research and Development Center, Kanazawa University, Ishikawa, Japan.
Publikováno v:
Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association [J Stroke Cerebrovasc Dis] 2023 Dec; Vol. 32 (12), pp. 107419. Date of Electronic Publication: 2023 Oct 14.
Results from a first-in-human study of dersimelagon, an investigational oral selective MC1R agonist.
Autor:
Ogasawara A; Mitsubishi Tanabe Pharma Corporation, 1-1-1, Marunouchi Chiyoda-ku, Tokyo, 100-8205, Japan. ogasawara.akihito@mm.mt-pharma.co.jp., Ogawa K; Mitsubishi Tanabe Pharma Corporation, 1-1-1, Marunouchi Chiyoda-ku, Tokyo, 100-8205, Japan., Ide R; Mitsubishi Tanabe Pharma Corporation, Kamoshida-cho, Aoba-ku, Yokohama, Kanagawa, 227-0033, Japan., Ikenaga Y; Mitsubishi Tanabe Pharma Corporation, Kamoshida-cho, Aoba-ku, Yokohama, Kanagawa, 227-0033, Japan., Fukunaga C; Mitsubishi Tanabe Pharma Corporation, Kamoshida-cho, Aoba-ku, Yokohama, Kanagawa, 227-0033, Japan., Nakayama S; Mitsubishi Tanabe Pharma Corporation, Kamoshida-cho, Aoba-ku, Yokohama, Kanagawa, 227-0033, Japan., Tsuda M; Mitsubishi Tanabe Pharma Corporation, Kamoshida-cho, Aoba-ku, Yokohama, Kanagawa, 227-0033, Japan.
Publikováno v:
European journal of clinical pharmacology [Eur J Clin Pharmacol] 2023 Jun; Vol. 79 (6), pp. 801-813. Date of Electronic Publication: 2023 Apr 15.
Autor:
Ikenaga Y; Department of Rehabilitation Medicine, Yawata Medical Center, Komatsu, Japan.; Council of Kaga Local Stroke Network, Nonoichi, Ishikawa, Japan., Fudeya M; Council of Kaga Local Stroke Network, Nonoichi, Ishikawa, Japan., Kusunoki T; Council of Kaga Local Stroke Network, Nonoichi, Ishikawa, Japan., Yamaguchi H; Department of Rehabilitation Medicine, Yawata Medical Center, Komatsu, Japan.
Publikováno v:
Progress in rehabilitation medicine [Prog Rehabil Med] 2023 Mar 31; Vol. 8, pp. 20230011. Date of Electronic Publication: 2023 Mar 31 (Print Publication: 2023).
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Shogenji M; Faculty of Health Sciences, Institute of Medical, Pharmaceutical and Health Sciences, Kanazawa University, Ishikawa, Japan., Yoshida M; Department of Women's Health Nursing & Midwifery, Tohoku University Graduate School of Medicine, Miyagi, Japan., Sumiya K; Department of Clinical Pharmacokinetics, Graduate School of Medical Sciences, Kanazawa University, Ishikawa, Japan., Shimada T; Department of Clinical Pharmacokinetics, Graduate School of Medical Sciences, Kanazawa University, Ishikawa, Japan.; Department of Hospital Pharmacy, University Hospital, Kanazawa University, Ishikawa, Japan., Ikenaga Y; Department of Rehabilitation Medicine, Yawata Medical Center, Ishikawa, Japan., Ogawa Y; Department of Pharmacy, Komatsu Municipal Hospital, Ishikawa, Japan., Hirako K; Frontier Science and Social Co-creation Initiative, Kanazawa University, Ishikawa, Japan., Sai Y; Department of Clinical Pharmacokinetics, Graduate School of Medical Sciences, Kanazawa University, Ishikawa, Japan.; Department of Hospital Pharmacy, University Hospital, Kanazawa University, Ishikawa, Japan.
Publikováno v:
Progress in rehabilitation medicine [Prog Rehabil Med] 2022 May 25; Vol. 7, pp. 20220028. Date of Electronic Publication: 2022 May 25 (Print Publication: 2022).
Autor:
Yoshida K; DMPK Research Laboratories, Sohyaku Innovative Research Division, Mitsubishi Tanabe Pharma Corporation, Kanagawa, Japan.; Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima, Japan., Doi Y; DMPK Research Laboratories, Sohyaku Innovative Research Division, Mitsubishi Tanabe Pharma Corporation, Kanagawa, Japan., Iwazaki N; DMPK Research Laboratories, Sohyaku Innovative Research Division, Mitsubishi Tanabe Pharma Corporation, Kanagawa, Japan., Yasuhara H; DMPK Research Laboratories, Sohyaku Innovative Research Division, Mitsubishi Tanabe Pharma Corporation, Kanagawa, Japan., Ikenaga Y; DMPK Research Laboratories, Sohyaku Innovative Research Division, Mitsubishi Tanabe Pharma Corporation, Kanagawa, Japan., Shimizu H; DMPK Research Laboratories, Sohyaku Innovative Research Division, Mitsubishi Tanabe Pharma Corporation, Kanagawa, Japan., Nakada T; DMPK Research Laboratories, Sohyaku Innovative Research Division, Mitsubishi Tanabe Pharma Corporation, Kanagawa, Japan., Watanabe T; DMPK Research Laboratories, Sohyaku Innovative Research Division, Mitsubishi Tanabe Pharma Corporation, Kanagawa, Japan., Tateno C; Research and Development Department, PhoenixBio Co., Ltd., Hiroshima, Japan., Sanoh S; Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima, Japan., Kotake Y; Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima, Japan.
Publikováno v:
Clinical and translational science [Clin Transl Sci] 2022 Jan; Vol. 15 (1), pp. 79-91. Date of Electronic Publication: 2021 Nov 07.
Publikováno v:
In Physica D: Nonlinear Phenomena 2000 135(3):305-330
Autor:
Ikenaga Y; Department of Rehabilitation Medicine, Yawata Medical Center, Ishikawa, Japan.; Council of Kaga Local Stroke Network, South Ishikawa, Japan., Kusunoki T; Council of Kaga Local Stroke Network, South Ishikawa, Japan., Yamaguchi H; Department of Rehabilitation Medicine, Yawata Medical Center, Ishikawa, Japan.
Publikováno v:
Progress in rehabilitation medicine [Prog Rehabil Med] 2021 Aug 07; Vol. 6, pp. 20210031. Date of Electronic Publication: 2021 Aug 07 (Print Publication: 2021).
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.